bevacizumab,panitumumab
amgen,roche,takeda
['bevacizumab', 'gicsm', 'panitumumab', '#gi', 'crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'colorectal', 'beva']
panitumumab superior to bevacizumab in combination w/ folfox for pts w/ left-sided ras wild-type metastatic #colorectalcancer. #asco22 #ascodailynews #gicsm #crcsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.